These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 20837573

  • 1. Early Pseudomonas aeruginosa infection in individuals with cystic fibrosis: is susceptibility testing justified?
    Macdonald D, Cuthbertson L, Doherty C, Campana S, Ravenni N, Taccetti G, Govan JR.
    J Antimicrob Chemother; 2010 Nov; 65(11):2373-5. PubMed ID: 20837573
    [Abstract] [Full Text] [Related]

  • 2. Emergence of carbapenem resistance in Pseudomonas aeruginosa isolates from a patient with cystic fibrosis in the absence of carbapenem therapy.
    Wolter DJ, Acquazzino D, Goering RV, Sammut P, Khalaf N, Hanson ND.
    Clin Infect Dis; 2008 Jun 15; 46(12):e137-41. PubMed ID: 18462098
    [Abstract] [Full Text] [Related]

  • 3. Consequences of combining cystic fibrosis- and non-cystic fibrosis-derived Pseudomonas aeruginosa antibiotic susceptibility results in hospital antibiograms.
    Bosso JA, Mauldin PD, Steed LL.
    Ann Pharmacother; 2006 Nov 15; 40(11):1946-9. PubMed ID: 17018687
    [Abstract] [Full Text] [Related]

  • 4. Antimicrobial use and Pseudomonas aeruginosa susceptibility profile in a cystic fibrosis centre.
    Manno G, Cruciani M, Romano L, Scapolan S, Mentasti M, Lorini R, Minicucci L.
    Int J Antimicrob Agents; 2005 Mar 15; 25(3):193-7. PubMed ID: 15737511
    [Abstract] [Full Text] [Related]

  • 5. Clinical impact of reducing routine susceptibility testing in chronic Pseudomonas aeruginosa infections in cystic fibrosis.
    Etherington C, Hall M, Conway S, Peckham D, Denton M.
    J Antimicrob Chemother; 2008 Feb 15; 61(2):425-7. PubMed ID: 18156280
    [Abstract] [Full Text] [Related]

  • 6. Variable antibiotic susceptibility in populations of Pseudomonas aeruginosa infecting patients with bronchiectasis.
    Gillham MI, Sundaram S, Laughton CR, Haworth CS, Bilton D, Foweraker JE.
    J Antimicrob Chemother; 2009 Apr 15; 63(4):728-32. PubMed ID: 19193658
    [Abstract] [Full Text] [Related]

  • 7. Effect of oxygen limitation on the in vitro activity of levofloxacin and other antibiotics administered by the aerosol route against Pseudomonas aeruginosa from cystic fibrosis patients.
    King P, Citron DM, Griffith DC, Lomovskaya O, Dudley MN.
    Diagn Microbiol Infect Dis; 2010 Feb 15; 66(2):181-6. PubMed ID: 19828274
    [Abstract] [Full Text] [Related]

  • 8. Routine susceptibility tests with ticarcillin and tobramycin in combination should be more appropriate than with each antibiotic alone in cystic fibrosis Pseudomonas aeruginosa.
    Lapointe JR, Bourget C, Mainville S, Lafleur L, Lagacé J, Montplaisir S.
    J Chemother; 1989 Jul 15; 1(4 Suppl):184-6. PubMed ID: 16312360
    [No Abstract] [Full Text] [Related]

  • 9. Induction of resistance to fluoroquinolones in clinical and environmental isolates of Pseudomonas aeruginosa.
    Prasad SV, Ballal M, Shivananda PG.
    Indian J Pathol Microbiol; 2007 Jan 15; 50(1):94-6. PubMed ID: 17474274
    [Abstract] [Full Text] [Related]

  • 10. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center.
    Ciofu O, Giwercman B, Pedersen SS, Høiby N.
    APMIS; 1994 Sep 15; 102(9):674-80. PubMed ID: 7946270
    [Abstract] [Full Text] [Related]

  • 11. Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype.
    Wolter DJ, Black JA, Lister PD, Hanson ND.
    J Antimicrob Chemother; 2009 Aug 15; 64(2):294-300. PubMed ID: 19468029
    [Abstract] [Full Text] [Related]

  • 12. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
    Hill D, Rose B, Pajkos A, Robinson M, Bye P, Bell S, Elkins M, Thompson B, Macleod C, Aaron SD, Harbour C.
    J Clin Microbiol; 2005 Oct 15; 43(10):5085-90. PubMed ID: 16207967
    [Abstract] [Full Text] [Related]

  • 13. Resistance to tobramycin and colistin in isolates of Pseudomonas aeruginosa from chronically colonized patients with cystic fibrosis under antimicrobial treatment.
    Valenza G, Radike K, Schoen C, Horn S, Oesterlein A, Frosch M, Abele-Horn M, Hebestreit H.
    Scand J Infect Dis; 2010 Dec 15; 42(11-12):885-9. PubMed ID: 20735333
    [Abstract] [Full Text] [Related]

  • 14. In Vitro Antibiotic Susceptibility of Initial Pseudomonas aeruginosa Isolates From United States Cystic Fibrosis Patients.
    VanDevanter DR, Van Dalfsen JM, Burns JL, Mayer-Hamblett N.
    J Pediatric Infect Dis Soc; 2015 Jun 15; 4(2):151-4. PubMed ID: 26407415
    [Abstract] [Full Text] [Related]

  • 15. [Investigation of biofilm formation and relationship with genotype and antibiotic susceptibility of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis].
    Coban AY, Ciftci A, Onuk EE, Erturan Z, Tanriverdi Cayci Y, Durupinar B.
    Mikrobiyol Bul; 2009 Oct 15; 43(4):563-73. PubMed ID: 20084909
    [Abstract] [Full Text] [Related]

  • 16. Pseudomonas aeruginosa from cystic fibrosis patients: study using whole cell RAPD and antibiotic susceptibility.
    Mereghetti L, Marquet-van der Mee N, Loulergue J, Rolland JC, Audurier A.
    Pathol Biol (Paris); 1998 May 15; 46(5):319-24. PubMed ID: 9769892
    [Abstract] [Full Text] [Related]

  • 17. Pseudomonas aeruginosa antibiotic susceptibility during long-term use of aztreonam for inhalation solution (AZLI).
    Oermann CM, McCoy KS, Retsch-Bogart GZ, Gibson RL, McKevitt M, Montgomery AB.
    J Antimicrob Chemother; 2011 Oct 15; 66(10):2398-404. PubMed ID: 21784781
    [Abstract] [Full Text] [Related]

  • 18. Characterization of clonal strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients in Ontario, Canada.
    Beaudoin T, Aaron SD, Giesbrecht-Lewis T, Vandemheen K, Mah TF.
    Can J Microbiol; 2010 Jul 15; 56(7):548-57. PubMed ID: 20651854
    [Abstract] [Full Text] [Related]

  • 19. [Optimization of the reading of antibiotic sensitivity by microdilution in Pseudomonas aeruginosa from cystic fibrosis using the oxidase test].
    Ballestero S, Vírseda I, Villaverde R, Baquero F.
    Enferm Infecc Microbiol Clin; 1993 Mar 15; 11(3):161-2. PubMed ID: 8499518
    [No Abstract] [Full Text] [Related]

  • 20. Clinical utility of synergy testing for multidrug-resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis: 'the motion for'.
    Saiman L.
    Paediatr Respir Rev; 2007 Sep 15; 8(3):249-55. PubMed ID: 17868923
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.